Craft

MetaStat

Stock Price

$0

2024-02-16

Market Capitalization

$20.6 K

2024-02-16

Revenue

$23.3 K

FY, 2018

MetaStat Summary

Company Summary

Overview
MetaStat is a biotechnology company focused on discovering and developing personalized diagnostic and therapeutic treatment solutions for cancer patients. Unlike surrogate cancer markers, which are indirect measures of cancer and its progression, driver-based biomarkers are the critical components of intracellular cancer pathways responsible for driving the aggressive activity of cancer cells. The Company's core expertise includes an understanding of the mechanisms and pathways that drive aggressive cancer, tumor cell invasion and metastasis.
Type
Public
Status
Active
Founded
2010
HQ
Boston, MA, US | view all locations
Website
http://www.metastat.com/
Cybersecurity rating
Sectors

Key People

  • Douglas A. Hamilton, President and Chief Executive Officer

    • Michael J. Donovan, Acting Chief Medical Officer

      • Daniel H. Schneiderman, Vice President of Finance & Corporate Secretary

        LocationsView all

        1 location detected

        • Boston, MA HQ

          United States

          27 Drydock Ave

        MetaStat Financials

        Summary Financials

        Revenue (FY, 2018)
        $23.3K
        Net income (FY, 2018)
        ($3.2M)
        Cash (FY, 2018)
        $316.9K

        Footer menu